APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single-target MET TKIs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Single-target MET TKIs Industry Growth and Trends Forecast to 2032

27 December 202591 pages

Choose your research edition.

Industry ResearchSingle-target MET TKIs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Single-target MET TKIs Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Single-target MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single-target MET TKIs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Single-target MET TKIs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Single-target MET TKIs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Single-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Single-target MET TKIs include CSPC Pharmaceutical, Asymchem, Shanghai Hutchison Pharmaceuticals, WuXi STA, Haihe Biopharma, Avistone Pharmaceuticals Biotechnology, Novartis and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Single-target MET TKIs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Single-target MET TKIs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Single-target MET TKIs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Single-target MET TKIs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Single-target MET TKIs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Single-target MET TKIs Market by Company

CSPC Pharmaceutical

Asymchem

Shanghai Hutchison Pharmaceuticals

WuXi STA

Haihe Biopharma

Avistone Pharmaceuticals Biotechnology

Novartis

Merck

Single-target MET TKIs Segment by Type

Tepotinib

Savolitinib

Capmatinib

Glumetinib

Vebreltinib

Other

Single-target MET TKIs Segment by Application

Retail Pharmacies

Hospital and Clinic

Other

Single-target MET TKIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single-target MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single-target MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single-target MET TKIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Single-target MET TKIs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Single-target MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tepotinib Table 2. Major Company of Savolitinib Table 3. Major Company of Capmatinib Table 4. Major Company of Glumetinib Table 5. Major Company of Vebreltinib Table 6. Major Company of Other Table 7. Global Single-target MET TKIs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Single-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 9. Global Single-target MET TKIs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Single-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Single-target MET TKIs Sales Market Share in Value by Type (2021-2026) Table 12. Global Single-target MET TKIs Price by Type (2021-2026) & (US$/Unit) Table 13. Global Single-target MET TKIs Sales by Type (2027-2032) & (K Units) Table 14. Global Single-target MET TKIs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Single-target MET TKIs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Single-target MET TKIs Sales Market Share in Value by Type (2027-2032) Table 17. Global Single-target MET TKIs Price by Type (2027-2032) & (US$/Unit) Table 18. North America Single-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 19. North America Single-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Single-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 21. Europe Single-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Single-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Single-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Single-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 25. Latin America Single-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Single-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Single-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 28. Single-target MET TKIs Industry Trends Table 29. Single-target MET TKIs Industry Drivers Table 30. Single-target MET TKIs Industry Opportunities and Challenges Table 31. Single-target MET TKIs Industry Restraints Table 32. Global Single-target MET TKIs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Single-target MET TKIs Revenue Market Share by Company (2021-2026) Table 34. Global Single-target MET TKIs Sales by Company (2021-2026) & (K Units) Table 35. Global Single-target MET TKIs Sales Share by Company (2021-2026) Table 36. Global Single-target MET TKIs Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Single-target MET TKIs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Single-target MET TKIs Major Company Production Sites and Headquarters Table 39. Global Single-target MET TKIs Company, Product Type & Application Table 40. Global Single-target MET TKIs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Single-target MET TKIs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Single-target MET TKIs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Single-target MET TKIs Sales by Region (2021-2026) & (K Units) Table 45. Global Single-target MET TKIs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Single-target MET TKIs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Single-target MET TKIs Sales Market Share in Value by Region (2021-2026) Table 48. Global Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Single-target MET TKIs Sales by Region (2027-2032) & (K Units) Table 50. Global Single-target MET TKIs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Single-target MET TKIs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Single-target MET TKIs Sales Market Share in Value by Region (2027-2032) Table 53. Global Single-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Single-target MET TKIs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Single-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 56. Global Single-target MET TKIs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Single-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Single-target MET TKIs Sales Market Share in Value by Application (2021-2026) Table 59. Global Single-target MET TKIs Price by Application (2021-2026) & (US$/Unit) Table 60. Global Single-target MET TKIs Sales by Application (2027-2032) & (K Units) Table 61. Global Single-target MET TKIs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Single-target MET TKIs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Single-target MET TKIs Sales Market Share in Value by Application (2027-2032) Table 64. Global Single-target MET TKIs Price by Application (2027-2032) & (US$/Unit) Table 65. North America Single-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 66. North America Single-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Single-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 68. Europe Single-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Single-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Single-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Single-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 72. Latin America Single-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Single-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Single-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 75. CSPC Pharmaceutical Company Information Table 76. CSPC Pharmaceutical Business Overview Table 77. CSPC Pharmaceutical Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. CSPC Pharmaceutical Single-target MET TKIs Product Portfolio Table 79. CSPC Pharmaceutical Recent Development Table 80. Asymchem Company Information Table 81. Asymchem Business Overview Table 82. Asymchem Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Asymchem Single-target MET TKIs Product Portfolio Table 84. Asymchem Recent Development Table 85. Shanghai Hutchison Pharmaceuticals Company Information Table 86. Shanghai Hutchison Pharmaceuticals Business Overview Table 87. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio Table 89. Shanghai Hutchison Pharmaceuticals Recent Development Table 90. WuXi STA Company Information Table 91. WuXi STA Business Overview Table 92. WuXi STA Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. WuXi STA Single-target MET TKIs Product Portfolio Table 94. WuXi STA Recent Development Table 95. Haihe Biopharma Company Information Table 96. Haihe Biopharma Business Overview Table 97. Haihe Biopharma Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Haihe Biopharma Single-target MET TKIs Product Portfolio Table 99. Haihe Biopharma Recent Development Table 100. Avistone Pharmaceuticals Biotechnology Company Information Table 101. Avistone Pharmaceuticals Biotechnology Business Overview Table 102. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio Table 104. Avistone Pharmaceuticals Biotechnology Recent Development Table 105. Novartis Company Information Table 106. Novartis Business Overview Table 107. Novartis Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Novartis Single-target MET TKIs Product Portfolio Table 109. Novartis Recent Development Table 110. Merck Company Information Table 111. Merck Business Overview Table 112. Merck Single-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Merck Single-target MET TKIs Product Portfolio Table 114. Merck Recent Development Table 115. North America Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 116. North America Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 117. North America Single-target MET TKIs Sales Market Share by Country (2021-2026) Table 118. North America Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 119. North America Single-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 120. North America Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 121. North America Single-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 122. North America Single-target MET TKIs Market Share by Country (2021-2026) Table 123. North America Single-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 124. North America Single-target MET TKIs Market Share Forecast by Country (2027-2032) Table 125. Europe Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. Europe Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 127. Europe Single-target MET TKIs Sales Market Share by Country (2021-2026) Table 128. Europe Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 129. Europe Single-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 130. Europe Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. Europe Single-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 132. Europe Single-target MET TKIs Market Share by Country (2021-2026) Table 133. Europe Single-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. Europe Single-target MET TKIs Market Share Forecast by Country (2027-2032) Table 135. Asia-Pacific Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Asia-Pacific Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 137. Asia-Pacific Single-target MET TKIs Sales Market Share by Country (2021-2026) Table 138. Asia-Pacific Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 139. Asia-Pacific Single-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 140. Asia-Pacific Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Asia-Pacific Single-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 142. Asia-Pacific Single-target MET TKIs Market Share by Country (2021-2026) Table 143. Asia-Pacific Single-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Asia-Pacific Single-target MET TKIs Market Share Forecast by Country (2027-2032) Table 145. Latin America Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Latin America Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 147. Latin America Single-target MET TKIs Sales Market Share by Country (2021-2026) Table 148. Latin America Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 149. Latin America Single-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 150. Latin America Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Latin America Single-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 152. Latin America Single-target MET TKIs Market Share by Country (2021-2026) Table 153. Latin America Single-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Latin America Single-target MET TKIs Market Share Forecast by Country (2027-2032) Table 155. Middle East and Africa Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Middle East and Africa Single-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 157. Middle East and Africa Single-target MET TKIs Sales Market Share by Country (2021-2026) Table 158. Middle East and Africa Single-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 159. Middle East and Africa Single-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 160. Middle East and Africa Single-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Middle East and Africa Single-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 162. Middle East and Africa Single-target MET TKIs Market Share by Country (2021-2026) Table 163. Middle East and Africa Single-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Middle East and Africa Single-target MET TKIs Market Share Forecast by Country (2027-2032) Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Single-target MET TKIs Distributors List Table 168. Single-target MET TKIs Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Single-target MET TKIs Image Figure 2. Global Single-target MET TKIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single-target MET TKIs Market Size (2021-2032) & (US$ Million) Figure 4. Global Single-target MET TKIs Sales (2021-2032) & (K Units) Figure 5. Tepotinib Image Figure 6. Global Tepotinib Sales YoY Growth (2021-2032) & (K Units) Figure 7. Savolitinib Image Figure 8. Global Savolitinib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Capmatinib Image Figure 10. Global Capmatinib Sales YoY Growth (2021-2032) & (K Units) Figure 11. Glumetinib Image Figure 12. Global Glumetinib Sales YoY Growth (2021-2032) & (K Units) Figure 13. Vebreltinib Image Figure 14. Global Vebreltinib Sales YoY Growth (2021-2032) & (K Units) Figure 15. Other Image Figure 16. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Single-target MET TKIs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Single-target MET TKIs Market Share by Type 2025 VS 2032 Figure 19. North America Single-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 20. North America Single-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 21. Europe Single-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Single-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Single-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Single-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Single-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Single-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Single-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Single-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Single-target MET TKIs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital and Clinic Image Figure 34. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Single-target MET TKIs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Single-target MET TKIs Market Share by Application 2025 VS 2032 Figure 39. North America Single-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 40. North America Single-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 41. Europe Single-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Single-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Single-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Single-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Single-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Single-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Single-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Single-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 49. North America Single-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Single-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Single-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Single-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Single-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Single-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Single-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Single-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Single-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Single-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Single-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Single-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Single-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Single-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Single-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Single-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Single-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Single-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Single-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Single-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Single-target MET TKIs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Single-target MET TKIs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Tepotinib
  • Savolitinib
  • Capmatinib
  • Glumetinib
  • Vebreltinib
  • Other
Applications
  • Retail Pharmacies
  • Hospital and Clinic
  • Other
Companies covered
  • CSPC Pharmaceutical
  • Asymchem
  • Shanghai Hutchison Pharmaceuticals
  • WuXi STA
  • Haihe Biopharma
  • Avistone Pharmaceuticals Biotechnology
  • Novartis
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Single-target MET TKIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Single-target MET TKIs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Single-target MET TKIs Market by Type
  6. 1.3.1 Tepotinib
  7. 1.3.2 Savolitinib
  8. 1.3.3 Capmatinib
  9. 1.3.4 Glumetinib
  10. 1.3.5 Vebreltinib
  11. 1.3.6 Other
  12. 1.4 Global Single-target MET TKIs Market Size by Type
  13. 1.4.1 Global Single-target MET TKIs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Single-target MET TKIs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Single-target MET TKIs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Single-target MET TKIs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Single-target MET TKIs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Single-target MET TKIs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Single-target MET TKIs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Single-target MET TKIs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Single-target MET TKIs Industry Trends
  2. 2.2 Single-target MET TKIs Industry Drivers
  3. 2.3 Single-target MET TKIs Industry Opportunities and Challenges
  4. 2.4 Single-target MET TKIs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Single-target MET TKIs Revenue (2021-2026)
  2. 3.2 Global Top Players by Single-target MET TKIs Sales (2021-2026)
  3. 3.3 Global Top Players by Single-target MET TKIs Price (2021-2026)
  4. 3.4 Global Single-target MET TKIs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Single-target MET TKIs Major Company Production Sites & Headquarters
  6. 3.6 Global Single-target MET TKIs Company, Product Type & Application
  7. 3.7 Global Single-target MET TKIs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Single-target MET TKIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Single-target MET TKIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Single-target MET TKIs Tier 1, Tier 2, and Tier 3
4 Single-target MET TKIs Regional Status and Outlook
  1. 4.1 Global Single-target MET TKIs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Single-target MET TKIs Historic Market Size by Region
  3. 4.2.1 Global Single-target MET TKIs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Single-target MET TKIs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Single-target MET TKIs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Single-target MET TKIs Forecasted Market Size by Region
  7. 4.3.1 Global Single-target MET TKIs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Single-target MET TKIs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Single-target MET TKIs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Single-target MET TKIs by Application
  1. 5.1 Single-target MET TKIs Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital and Clinic
  4. 5.1.3 Other
  5. 5.2 Global Single-target MET TKIs Market Size by Application
  6. 5.2.1 Global Single-target MET TKIs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Single-target MET TKIs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Single-target MET TKIs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Single-target MET TKIs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Single-target MET TKIs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Single-target MET TKIs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Single-target MET TKIs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Single-target MET TKIs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 CSPC Pharmaceutical
  2. 6.1.1 CSPC Pharmaceutical Company Information
  3. 6.1.2 CSPC Pharmaceutical Business Overview
  4. 6.1.3 CSPC Pharmaceutical Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 CSPC Pharmaceutical Single-target MET TKIs Product Portfolio
  6. 6.1.5 CSPC Pharmaceutical Recent Developments
  7. 6.2 Asymchem
  8. 6.2.1 Asymchem Company Information
  9. 6.2.2 Asymchem Business Overview
  10. 6.2.3 Asymchem Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Asymchem Single-target MET TKIs Product Portfolio
  12. 6.2.5 Asymchem Recent Developments
  13. 6.3 Shanghai Hutchison Pharmaceuticals
  14. 6.3.1 Shanghai Hutchison Pharmaceuticals Company Information
  15. 6.3.2 Shanghai Hutchison Pharmaceuticals Business Overview
  16. 6.3.3 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Hutchison Pharmaceuticals Single-target MET TKIs Product Portfolio
  18. 6.3.5 Shanghai Hutchison Pharmaceuticals Recent Developments
  19. 6.4 WuXi STA
  20. 6.4.1 WuXi STA Company Information
  21. 6.4.2 WuXi STA Business Overview
  22. 6.4.3 WuXi STA Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 WuXi STA Single-target MET TKIs Product Portfolio
  24. 6.4.5 WuXi STA Recent Developments
  25. 6.5 Haihe Biopharma
  26. 6.5.1 Haihe Biopharma Company Information
  27. 6.5.2 Haihe Biopharma Business Overview
  28. 6.5.3 Haihe Biopharma Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Haihe Biopharma Single-target MET TKIs Product Portfolio
  30. 6.5.5 Haihe Biopharma Recent Developments
  31. 6.6 Avistone Pharmaceuticals Biotechnology
  32. 6.6.1 Avistone Pharmaceuticals Biotechnology Company Information
  33. 6.6.2 Avistone Pharmaceuticals Biotechnology Business Overview
  34. 6.6.3 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Avistone Pharmaceuticals Biotechnology Single-target MET TKIs Product Portfolio
  36. 6.6.5 Avistone Pharmaceuticals Biotechnology Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novartis Single-target MET TKIs Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Merck
  44. 6.8.1 Merck Company Information
  45. 6.8.2 Merck Business Overview
  46. 6.8.3 Merck Single-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Merck Single-target MET TKIs Product Portfolio
  48. 6.8.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Single-target MET TKIs Sales by Country
  2. 7.1.1 North America Single-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Single-target MET TKIs Sales by Country (2021-2026)
  4. 7.1.3 North America Single-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Single-target MET TKIs Market Size by Country
  6. 7.2.1 North America Single-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Single-target MET TKIs Market Size by Country (2021-2026)
  8. 7.2.3 North America Single-target MET TKIs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Single-target MET TKIs Sales by Country
  2. 8.1.1 Europe Single-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Single-target MET TKIs Sales by Country (2021-2026)
  4. 8.1.3 Europe Single-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Single-target MET TKIs Market Size by Country
  6. 8.2.1 Europe Single-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Single-target MET TKIs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Single-target MET TKIs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Single-target MET TKIs Sales by Country
  2. 9.1.1 Asia-Pacific Single-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Single-target MET TKIs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Single-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Single-target MET TKIs Market Size by Country
  6. 9.2.1 Asia-Pacific Single-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Single-target MET TKIs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Single-target MET TKIs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Single-target MET TKIs Sales by Country
  2. 10.1.1 South America Single-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Single-target MET TKIs Sales by Country (2021-2026)
  4. 10.1.3 South America Single-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Single-target MET TKIs Market Size by Country
  6. 10.2.1 South America Single-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Single-target MET TKIs Market Size by Country (2021-2026)
  8. 10.2.3 South America Single-target MET TKIs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Single-target MET TKIs Sales by Country
  2. 11.1.1 Middle East and Africa Single-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Single-target MET TKIs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Single-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Single-target MET TKIs Market Size by Country
  6. 11.2.1 Middle East and Africa Single-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Single-target MET TKIs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Single-target MET TKIs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Single-target MET TKIs Value Chain Analysis
  2. 12.1.1 Single-target MET TKIs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Single-target MET TKIs Production Mode & Process
  7. 12.2 Single-target MET TKIs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Single-target MET TKIs Distributors
  10. 12.2.3 Single-target MET TKIs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst